TY - JOUR
T1 - Exome Sequencing and Identification of Phenocopies in Patients With Clinically Presumed Hereditary Nephropathies
AU - Riedhammer, Korbinian M.
AU - Braunisch, Matthias C.
AU - Günthner, Roman
AU - Wagner, Matias
AU - Hemmer, Clara
AU - Strom, Tim M.
AU - Schmaderer, Christoph
AU - Renders, Lutz
AU - Tasic, Velibor
AU - Gucev, Zoran
AU - Nushi-Stavileci, Valbona
AU - Putnik, Jovana
AU - Stajić, Nataša
AU - Weidenbusch, Marc
AU - Uetz, Barbara
AU - Montoya, Carmen
AU - Strotmann, Peter
AU - Ponsel, Sabine
AU - Lange-Sperandio, Baerbel
AU - Hoefele, Julia
N1 - Publisher Copyright:
© 2020 National Kidney Foundation, Inc.
PY - 2020/10
Y1 - 2020/10
N2 - Rationale & Objective: Hereditary nephropathies are clinically and genetically heterogeneous disorders. For some patients, the clinical phenotype corresponds to a specific hereditary disease but genetic testing reveals that the expected genotype is not present (phenocopy). The aim of this study was to evaluate the spectrum and frequency of phenocopies identified by using exome sequencing in a cohort of patients who were clinically suspected to have hereditary kidney disorders. Study Design: Cross-sectional cohort study. Setting & Participants: 174 unrelated patients were recruited for exome sequencing and categorized into 7 disease groups according to their clinical presentation. They included autosomal dominant tubulointerstitial kidney disease, Alport syndrome, congenital anomalies of the kidney and urinary tract, ciliopathy, focal segmental glomerulosclerosis/steroid-resistant nephrotic syndrome, VACTERL association, and “other.” Results: A genetic diagnosis (either likely pathogenic or pathogenic variant according to the guidelines of the American College of Medical Genetics) was established using exome sequencing in 52 of 174 (30%) cases. A phenocopy was identified for 10 of the 52 exome sequencing–solved cases (19%), representing 6% of the total cohort. The most frequent phenocopies (n = 5) were associated with genetic Alport syndrome presenting clinically as focal segmental glomerulosclerosis/steroid-resistant nephrotic syndrome. Strictly targeted gene panels (<25 kilobases) did not identify any of the phenocopy cases. Limitations: The spectrum of described phenocopies is small. Selection bias may have altered the diagnostic yield within disease groups in our study population. The study cohort was predominantly of non-Finnish European descent, limiting generalizability. Certain hereditary kidney diseases cannot be diagnosed by using exome sequencing (eg, MUC1-autosomal dominant tubulointerstitial kidney disease). Conclusions: Phenocopies led to the recategorization of disease and altered clinical management. This study highlights that exome sequencing can detect otherwise occult genetic heterogeneity of kidney diseases.
AB - Rationale & Objective: Hereditary nephropathies are clinically and genetically heterogeneous disorders. For some patients, the clinical phenotype corresponds to a specific hereditary disease but genetic testing reveals that the expected genotype is not present (phenocopy). The aim of this study was to evaluate the spectrum and frequency of phenocopies identified by using exome sequencing in a cohort of patients who were clinically suspected to have hereditary kidney disorders. Study Design: Cross-sectional cohort study. Setting & Participants: 174 unrelated patients were recruited for exome sequencing and categorized into 7 disease groups according to their clinical presentation. They included autosomal dominant tubulointerstitial kidney disease, Alport syndrome, congenital anomalies of the kidney and urinary tract, ciliopathy, focal segmental glomerulosclerosis/steroid-resistant nephrotic syndrome, VACTERL association, and “other.” Results: A genetic diagnosis (either likely pathogenic or pathogenic variant according to the guidelines of the American College of Medical Genetics) was established using exome sequencing in 52 of 174 (30%) cases. A phenocopy was identified for 10 of the 52 exome sequencing–solved cases (19%), representing 6% of the total cohort. The most frequent phenocopies (n = 5) were associated with genetic Alport syndrome presenting clinically as focal segmental glomerulosclerosis/steroid-resistant nephrotic syndrome. Strictly targeted gene panels (<25 kilobases) did not identify any of the phenocopy cases. Limitations: The spectrum of described phenocopies is small. Selection bias may have altered the diagnostic yield within disease groups in our study population. The study cohort was predominantly of non-Finnish European descent, limiting generalizability. Certain hereditary kidney diseases cannot be diagnosed by using exome sequencing (eg, MUC1-autosomal dominant tubulointerstitial kidney disease). Conclusions: Phenocopies led to the recategorization of disease and altered clinical management. This study highlights that exome sequencing can detect otherwise occult genetic heterogeneity of kidney diseases.
KW - Alport syndrome (AS)
KW - Hereditary kidney disease
KW - VACTERL
KW - autosomal dominant tubulointerstitial kidney disease (ADTKD)
KW - ciliopathy
KW - clinical phenotype
KW - congenital anomalies of the kidney and urinary tract (CAKUT)
KW - exome
KW - focal segmental glomerulosclerosis (FSGS)
KW - genetic diagnosis
KW - misdiagnosis
KW - next-generation sequencing (NGS)
KW - phenocopy
KW - steroid-resistant nephrotic syndrome (SRNS)
UR - http://www.scopus.com/inward/record.url?scp=85083829656&partnerID=8YFLogxK
U2 - 10.1053/j.ajkd.2019.12.008
DO - 10.1053/j.ajkd.2019.12.008
M3 - Article
C2 - 32359821
AN - SCOPUS:85083829656
SN - 0272-6386
VL - 76
SP - 460
EP - 470
JO - American Journal of Kidney Diseases
JF - American Journal of Kidney Diseases
IS - 4
ER -